Variant · Snv
CDKN2A D84Y
CI-VAR-00000596Explore in graph →CIViC 3333
Curated evidence
Evidence by cancer (1 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
civicProvenance
- Source
- CIViC — Clinical Interpretation of Variants in Cancer
- Dataset
- CIViC evidence items
- Version
- civic-2026-09-08
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- expert curation
- License
- CC0 1.0
- PMID
- 10498896
- Run
- ING-CIVIC-20260908-000001
| Molecular profile | Therapy | Type | Level | Direction · significance | Rating (1–5) | Status | Evidence | Source |
|---|---|---|---|---|---|---|---|---|
| Unmapped disease1unmapped disease | ||||||||
| CDKN2A D84Y | (functional) | Functional | D | Supports Loss Of Function | 3 | submitted | EID9319Analysis of several CDKN2A variants was performed to discover their functional impact. An in vitro binding assay found that CDKN2A D84Y resulted in complete loss of binding to CDK4 and CDK6. Protein s… (full text at CIViC) PMID 10498896 · Ruas et al., 1999 · Open in CIViC | civic |
ClinVar
Clinical significance (0)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
Data not yet available
No ClinVar interpretation attached to this variant.